Sign In
Buy NUMIF
$0.0308
-0.0014 (-4.35%)
At Close: Jul 31, 2026
Numinus Wellness announces partnership with HealingMaps
08:11am, Thursday, 22'nd Jun 2023
Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) has announced a partnership with HealingMaps, a leading source of accurate information about psychedelic-assisted therapy (PAT). The partnership will aim t
Numinus Wellness reveals partnership with the Multidisciplinary Association for Psychedelic Studies
08:31am, Thursday, 15'th Jun 2023
Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) revealed that it has partnered with the Multidisciplinary Association for Psychedelic Studies (MAPS) to support psychedelic experiential opportunities for
Numinus Wellness announces appointment of new chief financial officer
08:37am, Wednesday, 14'th Jun 2023
Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) has announced the appointment of Nikhil Handa as its new chief financial officer (CFO) effective from June 15, 2023, following an extensive executive search
Numinus to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on June 20-22, 2023
07:00am, Thursday, 08'th Jun 2023
VANCOUVER, BC , June 8, 2023 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evid
Numinus Wellness designated as a top research site for MindMed study
08:08am, Monday, 05'th Jun 2023
Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) said it has been designated as a top research site for MindMed Inc's (NASDAQ:MNMD, NEO:MMED) Phase 2b study on MM-120 (lysergide D-tartrate) for General
Numinus Wellness announces largest-of-its-kind study of psilocybin therapy to treat depression
08:33am, Tuesday, 30'th May 2023
Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) said its wholly-owned subsidiary Cedar Clinical Research (CCR) has begun studying COMP360 psilocybin therapy, an investigational new therapy for treatment-
Numinus Wellness positioned to lead in MDMA-assisted therapy as FDA approval nears
08:54am, Thursday, 25'th May 2023
Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) said it is well-positioned to be a key provider of MDMA-assisted therapy (MDMA-AT) as it expects Food and Drug Administration (FDA) approval for the thera
Numinus Wellness poised to outpace 'retrenching' psychedelic peers, Water Tower Research says
03:29pm, Thursday, 27'th Apr 2023
Numinus Wellness CEO Payton Nyquvest spoke with analysts at Water Tower Research last week, and the firm came away bullish on the company's prospects relative to its rivals. An analyst note publishe
Numinus Wellness Inc. (NUMIF) Q2 2023 Results Conference Call Transcript
09:45pm, Thursday, 13'th Apr 2023
Numinus Wellness Inc. (OTCQX:NUMIF) Q2 2023 Results Conference Call March 13, 2023 5:30 PM ET Company Participants Jamie Kokoska - Vice President, Investor Relations Payton Nyquvest - Founder and Chie
Numinus Wellness posts 580% 2Q revenue jump
04:42pm, Thursday, 13'th Apr 2023
Numinus Wellness Inc has posted a second quarter revenue jump of 581.1% year-over-year from $0.8 million to $5.4 million. For the quarter ended February 28, 2023, the company also reported an 820.9
Numinus Wellness launches new clinic licensing platform to accelerate expansion
07:58am, Tuesday, 11'th Apr 2023
Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) said it has launched a new clinic licensing model as it seeks to expand access to new regions across North America. The new Numinus Network platform offer
Imran Khan On Psychedelics - More We Don't Know Than We Do
07:00pm, Sunday, 02'nd Apr 2023
Imran Khan is Executive Director of the Berkeley Center for the Science of Psychedelics. Research behind psychedelics - way more that we don't know than we do.
Numinus Wellness chief clinical officer's contributions to mental health disorder studies featured in four peer-reviewed papers
10:21am, Tuesday, 21'st Mar 2023
Numinus Wellness Inc announced that its chief clinical officer Reid Robison has contributed to studies published in four peer-reviewed papers thus far in 2023 with his work in the treatment of mental
Numinus CEO Payton Nyquvest On Transforming Healthcare With Psychedelics
03:00pm, Sunday, 05'th Mar 2023
Mental health may be our biggest health issue and traditional medicine has had limited success in treating it. Psychedelic compounds have been healing people for thousands of years but there are chall
Numinus Wellness expands research capabilities with new Phoenix site
07:38am, Friday, 17'th Feb 2023
Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) announced that it has expanded its clinical research capabilities into Arizona with a new site in Phoenix, where the company operates mental health clinics.
